About this trial
the goal of the study is to improve the quality of life of patients on antipsychotic medications and increase the rate of compliance to treatment.
Primary objective:
1.To determine the effectiveness of probiotics to decrease the weight gained as a result of antipsychotic medications.
Secondary objective:
1\. To determine the effect of probiotic supplementation on the psychological state of patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult schizophrenia patients (18-45 years) on second generation antipsychotics Stable patients with a total positive and negative syndrome scale (PANSS) score of ≤60.
Disqualifiers
Taking probiotics, fiber supplements, antibiotics and laxatives in the last 6 weeks.
Comorbid gastrointestinal diseases, including active peptic ulcer, uncontrolled and recurrent diarrhea, gastrointestinal bleeding, and digestive system neoplastic diseases.
Trial design
Parallel
Treatments tested in this trial
lactobacillus LS
DrugProbiotic supplementation (Lacteol fort 10 billion) which contains culture medium and lactobacillus LS as active ingredients
Treatment groups
Trial outcomes
Primary outcomes
To determine the effectiveness of probiotics to decrease the weight gained as a result of antipsychotic medications.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.